Cargando…
P1194: A PHASE IB TRIAL OF ITACITINIB COMBINED WITH ALEMTUZUMAB IN PATIENTS WITH T-CELL PROLYMPHOCYTIC LEUKEMIA (T-PLL)
| Autores principales: | , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429128/ http://dx.doi.org/10.1097/01.HS9.0000847640.27266.62 |
| _version_ | 1784779339540201472 |
|---|---|
| author | Kadia, T. Ravandi, F. Borthakur, G. Jabbour, E. Montalban-Bravo, G. Adewale, L. Pierce, S. Lacke, C. Brandt, M. Short, N. Jain, N. Burger, J. Ferrajoli, A. Wierda, W. Kantarjian, H. |
| author_facet | Kadia, T. Ravandi, F. Borthakur, G. Jabbour, E. Montalban-Bravo, G. Adewale, L. Pierce, S. Lacke, C. Brandt, M. Short, N. Jain, N. Burger, J. Ferrajoli, A. Wierda, W. Kantarjian, H. |
| author_sort | Kadia, T. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9429128 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94291282022-08-31 P1194: A PHASE IB TRIAL OF ITACITINIB COMBINED WITH ALEMTUZUMAB IN PATIENTS WITH T-CELL PROLYMPHOCYTIC LEUKEMIA (T-PLL) Kadia, T. Ravandi, F. Borthakur, G. Jabbour, E. Montalban-Bravo, G. Adewale, L. Pierce, S. Lacke, C. Brandt, M. Short, N. Jain, N. Burger, J. Ferrajoli, A. Wierda, W. Kantarjian, H. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9429128/ http://dx.doi.org/10.1097/01.HS9.0000847640.27266.62 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Kadia, T. Ravandi, F. Borthakur, G. Jabbour, E. Montalban-Bravo, G. Adewale, L. Pierce, S. Lacke, C. Brandt, M. Short, N. Jain, N. Burger, J. Ferrajoli, A. Wierda, W. Kantarjian, H. P1194: A PHASE IB TRIAL OF ITACITINIB COMBINED WITH ALEMTUZUMAB IN PATIENTS WITH T-CELL PROLYMPHOCYTIC LEUKEMIA (T-PLL) |
| title | P1194: A PHASE IB TRIAL OF ITACITINIB COMBINED WITH ALEMTUZUMAB IN PATIENTS WITH T-CELL PROLYMPHOCYTIC LEUKEMIA (T-PLL) |
| title_full | P1194: A PHASE IB TRIAL OF ITACITINIB COMBINED WITH ALEMTUZUMAB IN PATIENTS WITH T-CELL PROLYMPHOCYTIC LEUKEMIA (T-PLL) |
| title_fullStr | P1194: A PHASE IB TRIAL OF ITACITINIB COMBINED WITH ALEMTUZUMAB IN PATIENTS WITH T-CELL PROLYMPHOCYTIC LEUKEMIA (T-PLL) |
| title_full_unstemmed | P1194: A PHASE IB TRIAL OF ITACITINIB COMBINED WITH ALEMTUZUMAB IN PATIENTS WITH T-CELL PROLYMPHOCYTIC LEUKEMIA (T-PLL) |
| title_short | P1194: A PHASE IB TRIAL OF ITACITINIB COMBINED WITH ALEMTUZUMAB IN PATIENTS WITH T-CELL PROLYMPHOCYTIC LEUKEMIA (T-PLL) |
| title_sort | p1194: a phase ib trial of itacitinib combined with alemtuzumab in patients with t-cell prolymphocytic leukemia (t-pll) |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429128/ http://dx.doi.org/10.1097/01.HS9.0000847640.27266.62 |
| work_keys_str_mv | AT kadiat p1194aphaseibtrialofitacitinibcombinedwithalemtuzumabinpatientswithtcellprolymphocyticleukemiatpll AT ravandif p1194aphaseibtrialofitacitinibcombinedwithalemtuzumabinpatientswithtcellprolymphocyticleukemiatpll AT borthakurg p1194aphaseibtrialofitacitinibcombinedwithalemtuzumabinpatientswithtcellprolymphocyticleukemiatpll AT jabboure p1194aphaseibtrialofitacitinibcombinedwithalemtuzumabinpatientswithtcellprolymphocyticleukemiatpll AT montalbanbravog p1194aphaseibtrialofitacitinibcombinedwithalemtuzumabinpatientswithtcellprolymphocyticleukemiatpll AT adewalel p1194aphaseibtrialofitacitinibcombinedwithalemtuzumabinpatientswithtcellprolymphocyticleukemiatpll AT pierces p1194aphaseibtrialofitacitinibcombinedwithalemtuzumabinpatientswithtcellprolymphocyticleukemiatpll AT lackec p1194aphaseibtrialofitacitinibcombinedwithalemtuzumabinpatientswithtcellprolymphocyticleukemiatpll AT brandtm p1194aphaseibtrialofitacitinibcombinedwithalemtuzumabinpatientswithtcellprolymphocyticleukemiatpll AT shortn p1194aphaseibtrialofitacitinibcombinedwithalemtuzumabinpatientswithtcellprolymphocyticleukemiatpll AT jainn p1194aphaseibtrialofitacitinibcombinedwithalemtuzumabinpatientswithtcellprolymphocyticleukemiatpll AT burgerj p1194aphaseibtrialofitacitinibcombinedwithalemtuzumabinpatientswithtcellprolymphocyticleukemiatpll AT ferrajolia p1194aphaseibtrialofitacitinibcombinedwithalemtuzumabinpatientswithtcellprolymphocyticleukemiatpll AT wierdaw p1194aphaseibtrialofitacitinibcombinedwithalemtuzumabinpatientswithtcellprolymphocyticleukemiatpll AT kantarjianh p1194aphaseibtrialofitacitinibcombinedwithalemtuzumabinpatientswithtcellprolymphocyticleukemiatpll |